The Relationship Between Scleroderma and Pulmonary Fibrosis

admin avatar

by admin |

Share this article:

Share article via email

Back in February, researchers presented a study investigating the therapeutic effect of the monoclonal antibody CM-101 in animal models of systemic sclerosis (SSc) and idiopathic pulmonary fibrosis (IPF).

In this Demystifying Medicine from McMaster University video, learn more about diseases associated with scleroderma, specifically pulmonary diseases including fibrosis.

Learn some simple facts about Idiopathic Pulmonary Fibrosis.

Scleroderma News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.